Table 2:
Treatment groups | Locomotor function test | ||
---|---|---|---|
Placing | Grasping | Righting | |
AAV5-scramble shRNA + Sham male | 5 (0) | 5 (0) | 5 (0) |
AAV5-scramble shRNA + SNL male | 5 (0) | 5 (0) | 5 (0) |
AAV5-TLR7 shRNA + Sham male | 5 (0) | 5 (0) | 5 (0) |
AAV5-TLR7 shRNA + SNL male | 5 (0) | 5 (0) | 5 (0) |
AAV5-GFP in male | 5 (0) | 5 (0) | 5 (0) |
AAV5-TLR7 in male | 5 (0) | 5 (0) | 5 (0) |
AAV5-scramble shRNA + Sham female | 5(0) | 5 (0) | 5 (0) |
AAV5-scramble shRNA + SNL female | 5 (0) | 5 (0) | 5 (0) |
AAV5-TLR7 shRNA + Sham female | 5 (0) | 5 (0) | 5 (0) |
AAV5-TLR7 shRNA + SNL female | 5 (0) | 5 (0) | 5 (0) |
n = 8–12 mice per group; five trials; Mean (SEM)